This Case describes and discusses about a 60 year old woman with a Type 2 Diabetes and COPD. The 3-year history of diabetes is seen for worsening dyspnea and cough. She has had chronic obstructive pulmonary disease (COPD) since age 55.
The Case specifies her cuyrretnt condition and asks question regarding the probable solution or medication.
It later gives a proper medication and discusses it in detail.
To read this case click on the following link.
Diabetic Case Study
Case-control studies contribute greatly to the research toolbox of an epidemiologist. They embody the strengths and weaknesses of observational epidemiology. Moreover, epidemiologists use them to study a huge variety of associations. To show this variety, we searched PubMed for topics investigated with case-control studies (panel 1).1–20 We identified diverse diseases and exposures, with outcomes ranging from earthquake deaths to racehorse injuries, and exposures ranging from pickled vegetables to pig farming. Read more…
The WHO and the European Union recognise that poor nutrition is a leading cause of the major non-communicable diseases, including CVD, type 2 diabetes, certain types of cancer, and contributes substantially to the global burden of disease, death and disability. Therefore, it is no surprise that Rayner and Scarborough report that, in the UK, food-related ill health is responsible for approximately 10% of morbidity and mortality and costs the National Health Service approximately £6 billion annually. In addition, the diets of those on low incomes may contribute significantly to health inequalities, as they can fall considerably short of the latest nutritional recommendations. Read more..
Abstract: Sanofi-aventis, the largest pharmaceutical company in Europe and the fourth-largest in the world, began a partnership with the World Health Organization in 2001 to fight sleeping sickness and other neglected diseases affecting the world’s poorest people. Initial discussions with the World Health Organization showed that a simple drug donation was not enough. Only combined action—drug donation, subsidies to fund distribution programmes and new research and development to improve treatments and diagnostics—could create a reasonable chance to bring sleeping sickness back under control. Over the first five years, 36 African countries benefited from the partnership. Click here to read more…
Pursuing a “go-it-alone” strategy through the end of phase II trials, thus postponing the decision of whom, if any, to partner with. The first two alternatives were somewhat consistent with Abgenix’ past business model that yielded revenues in two ways: 1) by issuing exclusive licenses to use XenoMouse for drug development targeting specific diseases to leading pharmaceutical and biotechnology companies and 2) by undertaking the early stages of XenoMouse based drug development and subsequently selling off the rights to further develop and bring the drugs onto the market. In contrast, the “go-it-alone” method would require an expansion of Abgenix’ resource base and capabilities: a more risky approach with the potential of a relatively high value generation. Click here to read more…
Executive Summary : Karamchand Appliances Pvt. Ltd(KAPL) was responsible for introducing ‘vaporizers’in the Indian mosquito repellant market. The Company has known for its product ‘All OUT’. From the decade of its launch All Out had converted a large number of customers into vaporizer users, and had also established itself as the market leader in the segment, with a 69 percent market share in 1999. For many years pepole has sufferd from mosquito problems today with over 255 species of mosquitoes – believed to be responsible for spreading diseases such as malaria and dengue fever – India has a large and growing market for mosquito repellants. Many methods are used in households for dealing with the mosquito menace. Click here to read more…
Biota is a leading anti-infective drug development company based in Melbourne, Australia and Oxford, UK. Although the company conducts research into a number of respiratory and other diseases, it is currently best known for the development of Relenza, the first-in-class drug commonly used to treat Swine and Avian Flu.
Biota Holding Limited has four wholly-owned subsidiaries – Biota Scientific Management which is the company’s research and development arm; Biota Europe Ltd, which manages all UK activity, plus Biota Respiratory Research and Biota Investment, both of which hold intellectual property assets for the group. Locally Biota employs around 80 research and development staff plus an administrative team of 15. In the UK, there are an additional 13 employees. Read more..
Register to mark your Comments
Ayurveda, an ancient system of treatment and healthcare, has expanded tremendously in recent times. This has led to the mushrooming of ayurvedic centres across the country. The various herbal combinations, treatments and massage procedures used in Ayurveda have been known to treat many disorders and diseases. Speaking about his centre, Dr Mruthyunjaya, CEO, Shathayu Ayurveda, says : “Our ayurvedic centre is owned and run by doctors. Majority of the ayurvedic centres in India are more like massage centres, rather than pure treatment centre; whereas in Shathayu, we target prevention, cure and wellness. So we provide a holistic ayurvedic package. All our treatments are research-based. We have around 25 categories of treatment, and we are in the process of adding more treatments with time.”
During the last three decades, the world has accepted the Indian disciplines of yoga, meditation and Ayurveda. People from abroad have shown great interest in Ayurveda. However, to extend its reach across the world many organised players took the franchise route to expand their presence worldwide. Click here to read more…
This study is an effort to find a connection between the high number of people on sick leave, the occupational health situation at the workplace, and stronger market competition and globalization forces. The basis for the study is statistics, mainly on injuries and diseases, interviews with people in different positions with either long experience within the safety and health situation or otherwise having insight into organizations? internal situation, and a literature review…click here for details